Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
308.2 USD | +0.27% | +2.63% | +6.96% |
May. 28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
May. 28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.96% | 165B | |
+41.91% | 748B | |
+34.11% | 598B | |
-6.62% | 356B | |
+18.13% | 325B | |
+3.98% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+1.88% | 166B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Sector Update: Health Care Stocks Mixed in Afternoon Trading